Department of Neurosurgery, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.
Neurosciences Clinical Trials Unit, King's College Hospital, London, UK.
Acta Neurochir (Wien). 2021 Feb;163(2):317-329. doi: 10.1007/s00701-020-04652-8. Epub 2020 Nov 21.
The novel severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic has had drastic effects on global healthcare with the UK amongst the countries most severely impacted. The aim of this study was to examine how COVID-19 challenged the neurosurgical delivery of care in a busy tertiary unit serving a socio-economically diverse population.
A prospective single-centre cohort study including all patients referred to the acute neurosurgical service or the subspecialty multidisciplinary teams (MDT) as well as all emergency and elective admissions during COVID-19 (18th March 2020-15th May 2020) compared to pre-COVID-19 (18th of January 2020-17th March 2020). Data on demographics, diagnosis, operation, and treatment recommendation/outcome were collected and analysed.
Overall, there was a reduction in neurosurgical emergency referrals by 33.6% and operations by 55.6% during the course of COVID-19. There was a significant increase in the proportion of emergency operations performed during COVID-19 (75.2% of total, n=155) when compared to pre-COVID-19 (n = 198, 43.7% of total, p < 0.00001). In contrast to other published series, the 30-day perioperative mortality remained low (2.0%) with the majority of post-operative COVID-19-infected patients (n = 13) having underlying medical co-morbidities and/or suffering from post-operative complications.
The capacity to safely treat patients requiring urgent or emergency neurosurgical care was maintained at all times. Strategies adopted to enable this included proactively approaching the referrers to maintain lines of communications, incorporating modern technology to run clinics and MDTs, restructuring patient pathways/facilities, and initiating the delivery of NHS care within private sector hospitals. Through this multi-modal approach we were able to minimize service disruptions, the complications, and mortality.
新型严重急性呼吸综合征冠状病毒 2(COVID-19)大流行对全球医疗保健产生了巨大影响,英国是受影响最严重的国家之一。本研究的目的是研究 COVID-19 如何挑战为服务于社会经济多样化人群的繁忙三级单位提供神经外科护理。
一项前瞻性单中心队列研究,纳入了在 COVID-19 期间(2020 年 3 月 18 日至 5 月 15 日)转至急性神经外科服务或专科多学科团队(MDT)以及所有急诊和择期入院的所有患者,以及 COVID-19 之前(2020 年 1 月 18 日至 3 月 17 日)。收集并分析了人口统计学、诊断、手术和治疗建议/结果的数据。
总体而言,COVID-19 期间神经外科急诊转介减少了 33.6%,手术减少了 55.6%。与 COVID-19 之前相比(n = 198,占总数的 43.7%),COVID-19 期间进行的急诊手术比例显著增加(占总数的 75.2%,n = 155,p < 0.00001)。与其他已发表的系列不同,30 天围手术期死亡率仍然较低(2.0%),大多数术后 COVID-19 感染患者(n = 13)患有潜在的合并症和/或患有术后并发症。
始终保持安全治疗需要紧急或紧急神经外科护理的患者的能力。为此采用的策略包括主动与转介者联系以保持沟通渠道畅通,利用现代技术开展诊所和 MDT,重组患者途径/设施,并在私营部门医院提供国民保健服务。通过这种多模式方法,我们能够最大限度地减少服务中断、并发症和死亡率。